- What other names is Yerba Santa known by?
- What is Yerba Santa?
- How does Yerba Santa work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Yerba Santa.
Bear's Weed, Consumptive's Weed, Eriodictyon, Eriodictyon californicum, Eriodictyon glutinosum, Gum Bush, Gum Plant, Herbe des Montagnes, Herbe à Ourse, Herbe Sacrée, Herbe Sainte, Hierba Santa, Holy Herb, Holy Weed, Mountain Balm, Sacred Herb, Tarweed, Wigandia californicum.
Yerba santa is an herb. The leaf is used to make medicine.
Yerba santa is used for respiratory conditions including coughs, colds, tuberculosis, asthma, and chronic bronchitis. It is also used for fever and dry mouth. Some people use it to relieve muscle spasms, to loosen phlegm, and as a tonic.
In foods and beverages, an extract of yerba santa is used as a flavoring.
In the manufacturing of medications, yerba santa is used to mask the bitter taste of certain drugs.
Insufficient Evidence to Rate Effectiveness for...
Yerba santa contains chemicals that are thought to loosen mucus in the chest and may increase urination.
Yerba santa is LIKELY SAFE when eaten in amounts commonly found in food or when taken by mouth for medicinal reasons. However, the potential side effects are not known.
There is not enough information to know whether yerba santa is safe when put on the skin.
Special Precautions & Warnings:Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking yerba santa if you are pregnant or breast-feeding. Stay on the safe side and avoid use.
LithiumInteraction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Yerba santa might have an effect like a water pill or "diuretic." Taking yerba santa might decrease how well the body gets rid of lithium. This could increase how much lithium is in the body and result in serious side effects. Talk with your healthcare provider before using this product if you are taking lithium. Your lithium dose might need to be changed.
The appropriate dose of yerba santa depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for yerba santa. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Health Solutions From Our Sponsors
Ahmed, M. S., Galal, A. M., Ross, S. A., Ferreira, D., ElSohly, M. A., Ibrahim, A. S., Mossa, J. S., and El Feraly, F. S. A weakly antimalarial biflavanone from Rhus retinorrhoea. Phytochemistry 2001;58(4):599-602. View abstract.
American Pharmaceutical Association. The National Formulary, 9th Ed. 1950;195-197.
Aviado, D. M., Bacalzo, L. V., and Belej, M. A. Prevention of acute pulmonary insufficiency by eriodictyol. J.Pharmacol.Exp.Ther. 1974;189(1):157-166. View abstract.
Bacon, JD, Hannan, GL, Fang, N, and Mabry, TJ. Chemosystematics of the Hydrophyllaceae: flavonoids of three species of Eriodictyon. Biochem System Ecol 1986;14:591-595.
Bohm, BA and Constant, H. Leaf surface flavonoids of Eriodictyon trichocalyx. Biochem System Ecol 1990;18:491-492.
BOOTH, A. N., JONES, F. T., and DeEDS, F. Metabolic fate of hesperidin, eriodictyol, homoeridictyol, and diosmin. J.Biol.Chem. 1958;230(2):661-668. View abstract.
Brown, JP. A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mut Res 1980;75:243-277.
Felter, HW and Lloy, JU. King's American Dispensatory, 18th ed., 1898.
Geissman, TA. The isolation of eriodictyol and homoeriodictyol an improved procedure. J Am Chem Soc 1940;62:3258-3259.
Gradolatto, A., Basly, JP, Berges, R., Teyssier, C., Chagnon, MC, Siess, MH, and Canivenc-Lavi, MC. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 2005;33:49-54.
Grael, C. F., Vichnewski, W., Souza, G. E., Lopes, J. L., Albuquerque, S., and Cunha, W. R. A study of the trypanocidal and analgesic properties from Lychnophora granmongolense (Duarte) Semir & Leitao Filho. Phytother.Res. 2000;14(3):203-206. View abstract.
Heim, KE, Tagliaferro, AR, and Bobily, DJ. Flavonoid antioxidants: chemistry, metabolism and stucture activity relationships. J Nutr Biochem 2002;13:572-584.
Huguet, A. I., Manez, S., and Alcaraz, M. J. Superoxide scavenging properties of flavonoids in a non-enzymic system. Z.Naturforsch.[C.] 1990;45(1-2):19-24. View abstract.
Johnson, ND and Brain, SA. The response of leaf resin to artificial herbivory in Eriodictyon californicum. Biochem System Ecol 1985;13:5-9.
Johnson, ND. Flavonoid aglycones from Eriodictyon californicum resin and their implications for herbivory and UV screening. Biochem System Ecol 1983;11:211-215.
Matsuda, H, Wang, T, Managi, H, and Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 2003;11:5317-5323.
Matsuo, M., Sasaki, N., Saga, K., and Kaneko, T. Cytotoxicity of flavonoids toward cultured normal human cells. Biol.Pharm.Bull. 2005;28(2):253-259. View abstract.
Mitsuharu O, Masako T, Katsuko K, and Tomoka T. Active oxygen scavenger or cosmetic composition, 2003. Japanese patent 2003183120.
Mitsuharu, O, Hiroyuki, K, Makoto U, and Nobuyasu M. Maillard reaction inhibitor, 2004. Japanese patent 2004189663.
Miyake, Y, Yamamoto, K, and Osawa, T. Metabolism of antioxidant in lemon fruit (Citrus limon Burm.f.) by human intestinal bacteria. J Agric Food Chem 1997;45:3738-3742.
Mori A, Nishino C, Enoki N., and Tawata S. Cytotoxicity of plant flavonoids against HeLa cells. Phytochem 1988;27:1017-1020.
Mossler, G. The chemical investigation of Eriodictyon glutinosum. Ann 1907;351:233-254.
Rechner, A. R., Smith, MA, Kuhnle, F, Gibson GR, Debnam, ES, Srai, SKS, Moore, KP, and Rice-Evans, CA. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Rad Biol Med 2004;36:212-225.
Remington, JP, Wood, HC, and et al. The dispensatory of the United States of America, 20th ed.1918.
Ritter, FW. Eriodictyon glutinosum. Am J Pharm 1895;67:1-7.
Takuya, Y., Mayumi, S., Homare, T., and Fuminobu, Y. Cosmetic, 2002. Japanese patent 2002234812.
The British Pharmaceutical Codex. Council of the Pharmaceutical Society of Great Britain, 1911.
Thiyagarajah, P., Kuttan, S. C., Lim, S. C., Teo, T. S., and Das, N. P. Effect of myricetin and other flavonoids on the liver plasma membrane Ca2+ pump. Kinetics and structure-function relationships. Biochem.Pharmacol. 3-1-1991;41(5):669-675. View abstract.
Tsimogiannis, DI and Oreopoulou, V. Free radical scavenging and antioxidant activity of 5,7,3',4'-hydroxy substituted flavonoids. Inn Food Sci Emerg Tech 2004;5:523-528.
van Zanden, J. J., Geraets, L., Wortelboer, H. M., van Bladeren, P. J., Rietjens, I. M., and Cnubben, N. H. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem.Pharmacol. 4-15-2004;67(8):1607-1617. View abstract.
Way, TD, Kao, MC, and Lin, JK. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu overexpressing breast cancer cells. FEBS Lett 2005;578:145-152.
Westmoreland, J. Yerba santa in influenza. Lancet 1898;151(3895):1114-1115.
Liu YL, Ho DK, Cassady JM, et al. Isolation of potential cancer chemopreventive agents from Eriodictyon californicum. J Nat Prod 1992;55:357-63. View abstract.
Weiner MA, Weiner JA. Herbs that heal: prescription for herbal healing. Mill Valley, CA:Quantum Books, 1999.